1.Pseudolymphoma Induced by Ear Piercing.
Chang Hun HUH ; Je Young PARK ; Chong Hyun WON ; Hee Chul EUN ; Sang Eun MOON
Annals of Dermatology 2004;16(1):9-12
We present a patient who developed a pseudolymphoma after ear piercing. A patch test showed gold sensitivity. Therefore, long standing dermal exposure to gold from a pierced-type earring might have produced the patient's disease. This patient did not respond to an intralesional steroid injection and was finally treated with a complete resection of the lesion. It is proposed that every patient with a hyperplastic lesion in the ear lobe should be taken a biopsy in order to rule out the possibility of a pseudolymphoma. When a pseudolymphoma develops in the ear lobe, a complete surgical excision could be the treatment of choice, especially for the prevention of recurrence.
Biopsy
;
Body Piercing*
;
Ear*
;
Humans
;
Patch Tests
;
Pseudolymphoma*
;
Recurrence
2.Two Cases of Segmantal Dilatation of the Intestine in Newborn Infants.
Tai Sung JUNG ; Eun Sil LEE ; Son Moon SHIN ; Young Soo HUH
Korean Journal of Perinatology 1997;8(3):315-323
Segmental dilatation of small intestine or colon can induce signs of intestinal obstruction, such as abdominal distension, vomiting and constipation. There are no anatomical gross obstructive lesions, and moreover, ganglion cells are observed in both dilated and undilated distal segments of the intestine. It often accompanied by other congenital anomalies. We reported two cases of segmental dilatation of the intestine in the newborn infants, one in small intestine and the other in colon, with brief review of the related literatures.
Colon
;
Constipation
;
Dilatation*
;
Ganglion Cysts
;
Humans
;
Infant, Newborn*
;
Intestinal Obstruction
;
Intestine, Small
;
Intestines*
;
Vomiting
3.Merkel Cell Carcinoma Coexistent with Epidermal Cyst in an Immunosuppressed Man.
Young In JEONG ; Joon Won HUH ; Geon KIM ; Eun Jung KIM ; Hyang Joon PARK ; Mihn Sook JUE
Korean Journal of Dermatology 2014;52(5):368-370
No abstract available.
Carcinoma, Merkel Cell*
;
Epidermal Cyst*
;
Immunosuppression
4.Pilomatricoma on the Ear Helix.
Young In JEONG ; Joon Won HUH ; Geon KIM ; Mihn Sook JUE ; Hyang Joon PARK ; Eun Jung KIM
Korean Journal of Dermatology 2015;53(3):261-262
No abstract available.
Ear*
;
Pilomatrixoma*
5.A Case of Adult Colloid Milium on the Scalp.
Joon Won HUH ; Young In JEONG ; Geon KIM ; Mihn Sook JUE ; Hyangjoon PARK ; Eun Jung KIM
Korean Journal of Dermatology 2015;53(9):740-741
6.Photodynamic Therapy with Methyl Aminolevulinate for Disseminated Superficial Porokeratosis.
Joon Won HUH ; Young In JEONG ; Geon KIM ; Mihn Sook JUE ; Eun Jung KIM ; Hyangjoon PARK
Korean Journal of Dermatology 2014;52(10):757-758
No abstract available.
Photochemotherapy*
;
Porokeratosis*
8.Experience with inhaled nitric oxide therapy in patient with neurogenic pulmonary edema: A case report.
Eun Sun PARK ; In Young HUH ; Dae Young KIM ; Soon Eun PARK ; Ok Kyung LEE
Anesthesia and Pain Medicine 2010;5(3):236-239
Neurogenic pulmonary edema is known in patients after head injuries or other cerebral lesions. Typically, this form of pulmonary edema occurs minutes to hours after central nervous system injury and may manifest during the perioperative period. It is always a life-threatening symptom after increased intracranial pressure (ICP), where immediate therapeutic interventions are imperative. Rapid initiation of strategies aimed at ameliorating hypoxia including support of oxygenation and ICP reduction is paramount. We report a case that responded dramatically to inhaled nitric oxide (NO). This therapy, to our experience, seems to provide a way not to reduce pulmonary hypertension, but to improve ventilation-perfusion mismatch for the treatment of refractory hypoxemia in neurogenic pulmonary edema patient.
Anoxia
;
Central Nervous System
;
Craniocerebral Trauma
;
Humans
;
Hypertension, Pulmonary
;
Intracranial Pressure
;
Nitric Oxide
;
Oxygen
;
Perioperative Period
;
Pulmonary Edema
9.Smart device-based testing for medical students in Korea: satisfaction, convenience, and advantages.
Eun Young LIM ; Mi Kyoung YIM ; Sun HUH
Journal of Educational Evaluation for Health Professions 2017;14(1):7-
The aim of this study was to investigate respondents' satisfaction with smart device-based testing (SBT), as well as its convenience and advantages, in order to improve its implementation. The survey was conducted among 108 junior medical students at Kyungpook National University School of Medicine, Korea, who took a practice licensing examination using SBT in September 2015. The survey contained 28 items scored using a 5-point Likert scale. The items were divided into the following three categories: satisfaction with SBT administration, convenience of SBT features, and advantages of SBT compared to paper-and-pencil testing or computer-based testing. The reliability of the survey was 0.95. Of the three categories, the convenience of the SBT features received the highest mean (M) score (M= 3.75, standard deviation [SD]= 0.69), while the category of satisfaction with SBT received the lowest (M= 3.13, SD= 1.07). No statistically significant differences across these categories with respect to sex, age, or experience were observed. These results indicate that SBT was practical and effective to take and to administer.
Gyeongsangbuk-do
;
Humans
;
Korea*
;
Licensure
;
Personal Satisfaction
;
Republic of Korea
;
Students, Medical*
;
Tablets
10.The Overxpression of p53 in gestational Trophoblastic Disease and Normal Human Placenta.
Sung Ook WHANG ; Jong Hyeok KIM ; Jooryung HUH ; Yong Man KIM ; Young Tak KIM ; Joo Hyun NAM ; Jung Eun MOK
Korean Journal of Gynecologic Oncology and Colposcopy 1997;8(3):300-314
Mutations in the tumor suppressor p53 gene are the most frequently observed genetic lesions in human cancers. It seems that wild type p53 does significant role on growth and differentiation of normal cells, Mutations and allelic loss of the p53 gene are thought to be a cause of tumor development and to be correlated with the prognostic factors in various human cancers such as breast, ovary and lung cancer. Mutant p53 proteins have a prolonged half-life and can be detected by immunohistochemistry. In case of GTD(gestational trophoblastic disease), although the mutation of p53 gene mutation was revealed to be very rare, the overexpression of p53 in immunohistochemical staining has been reported in wide range of discrepancy and its role or prognostic significance in GTD is uncertain. This study is performed to define the status of p53 overexpression in GTD and to evaluate the correlations between p53 overexpression and prognostic factors of GTD. THE RESULTS WERE AS FOLLOWS: 1. p53 overexpression was detected in none of normal placental tissue, in 58.3%(14/24) of hydatidiform mole, in 15%(6/8) of invasive mole, in 75%(3/4) of choriocarcinoma, and in 100%(1/1) of placental site trophoblastic tumor, and showed significant difference between normal placenta and GTD. We could not find any difference of the p53 overexpression between benign group(H-mole) of GTD and malignant one(invasive mole, choriocarcinoma, and placental site trophoblastic tumor) 2. In H-mole, low-risk group showed significantly higher prevalence of p53 overexpression than high-risk group did. In malignant group, there is no difference in the prevalence of p53 overexpression between early(FIGO stage I) and late(II- IV)stage-diseases, but the prevalence of p53 overexpression of low-risk group is slightly higher than that of high-risk group although we failed to find statistical significance. In conclusion, the high prevalence of p53 overexpression in GTD suggests that p53 may have a certain role in the pathogenesis of GTD or at least represent generalized DNA damage or genetic instability of GTD. And the higher prevalence of p53 overexpression in low-risk group suggests that accumulation of wild-type p53 may be related with favorable prognosis in GTD.
Breast
;
Choriocarcinoma
;
DNA Damage
;
Female
;
Genes, p53
;
Gestational Trophoblastic Disease*
;
Half-Life
;
Humans*
;
Hydatidiform Mole
;
Hydatidiform Mole, Invasive
;
Immunohistochemistry
;
Loss of Heterozygosity
;
Lung Neoplasms
;
Ovary
;
Placenta*
;
Pregnancy
;
Prevalence
;
Prognosis
;
Trophoblastic Tumor, Placental Site
;
Trophoblasts